$4.58
0.143.15%
At close: Aug 24, 5:00 PM EST
$4.58
0.143.15%
Pre-Market: 4:37 AM EST
Cytek Biosciences Inc
CTKBNASDAQ
Cytek Biosciences Earnings & Forecasts
Cytek Biosciences (CTKB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Cytek Biosciences Guidance
Cytek Biosciences (CTKB) last issued guidance on August 5, 2026 for fiscal year 2026. The company guided revenue in the range of $207M - $212M for the period.
Compared to prior guidance, Cytek Biosciences maintained its revenue forecast from a prior range of $205M - $212M.
Cytek Biosciences has issued 22 guidance updates between November 9, 2022 and August 5, 2026. During this period, the company raised its outlook 5 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.02 | $-0.09 | $-0.01 | $-0.01 |
| Actual | $-0.09 | $-0.15 | $-0.34 | $-0.04 |
| Surprise | -350.0% | -66.7% | -3300.0% | -300.0% |
| Revenue | ||||
| Estimate | $48.5M | $44.2M | $58.8M | $51.2M |
| Actual | $48.1M | $44.1M | $62.1M | $52.3M |
| Surprise | -0.81% | -100.0% | +5.68% | +2.04% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.07 | $0.02 | $-0.08 | $-0.02 |
| Revenue | ||||
| Consensus | $53.0M | $63.7M | — | — |
